136 related articles for article (PubMed ID: 10519963)
21. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the growth-inhibitory and apoptosis-inducing activities of black tea theaflavins and green tea catechin on murine myeloid leukemia cells.
Lung HL; Ip WK; Chen ZY; Mak NK; Leung KN
Int J Mol Med; 2004 Mar; 13(3):465-71. PubMed ID: 14767581
[TBL] [Abstract][Full Text] [Related]
23. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Weisburg JH; Weissman DB; Sedaghat T; Babich H
Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):191-200. PubMed ID: 15504155
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of oral cancer by green tea.
Hsu SD; Singh BB; Lewis JB; Borke JL; Dickinson DP; Drake L; Caughman GB; Schuster GS
Gen Dent; 2002; 50(2):140-6. PubMed ID: 12004708
[TBL] [Abstract][Full Text] [Related]
25. Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells.
Peng G; Wargovich MJ; Dixon DA
Cancer Lett; 2006 Jul; 238(2):260-70. PubMed ID: 16157446
[TBL] [Abstract][Full Text] [Related]
26. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
27. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha.
Trompezinski S; Denis A; Schmitt D; Viac J
Arch Dermatol Res; 2003 Jul; 295(3):112-6. PubMed ID: 12811578
[TBL] [Abstract][Full Text] [Related]
29. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.
Benelli R; Venè R; Bisacchi D; Garbisa S; Albini A
Biol Chem; 2002 Jan; 383(1):101-5. PubMed ID: 11928805
[TBL] [Abstract][Full Text] [Related]
30. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
31. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
[TBL] [Abstract][Full Text] [Related]
32. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.
Kazi A; Smith DM; Daniel K; Zhong S; Gupta P; Bosley ME; Dou QP
In Vivo; 2002; 16(6):397-403. PubMed ID: 12494882
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
34. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
[TBL] [Abstract][Full Text] [Related]
35. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
36. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
Jung YD; Ellis LM
Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of fibroblast growth factors by green tea.
Sartippour MR; Heber D; Zhang L; Beatty P; Elashoff D; Elashoff R; Go VL; Brooks MN
Int J Oncol; 2002 Sep; 21(3):487-91. PubMed ID: 12168090
[TBL] [Abstract][Full Text] [Related]
39. Green tea and its anti-angiogenesis effects.
Rashidi B; Malekzadeh M; Goodarzi M; Masoudifar A; Mirzaei H
Biomed Pharmacother; 2017 May; 89():949-956. PubMed ID: 28292023
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of EGCG: a patent review.
Chakrawarti L; Agrawal R; Dang S; Gupta S; Gabrani R
Expert Opin Ther Pat; 2016 Aug; 26(8):907-16. PubMed ID: 27338088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
